These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 12280300)
21. [Do's and don'ts in treating amenorrhea in women taking the minipill]. Janaud A Contracept Fertil Sex (Paris); 1985 Jun; 13(6):863-5. PubMed ID: 12267302 [TBL] [Abstract][Full Text] [Related]
22. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data]. Gaspard U; Dubois M Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606 [TBL] [Abstract][Full Text] [Related]
25. [Evaluation of the efficacy of a venotonic capillary protector in the treatment of metrorrhagia due to IUD or micropill contraception]. Monteil-seurin J; Bernard-fernier MF; Martinaggi P; Demarez JP; Cauquil J; Lafont A Contracept Fertil Sex (Paris); 1985 May; 13(5):721-5. PubMed ID: 12267101 [TBL] [Abstract][Full Text] [Related]
26. Current perspectives on combination oral contraceptives. Smith MA; Youngkin EQ Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284 [TBL] [Abstract][Full Text] [Related]
27. Lyndiol (1 mg)--evaluation of a new low dose oral contraceptive. Banerjee SK Antiseptic; 1977 Sep; 74(9):531-3. PubMed ID: 12281247 [TBL] [Abstract][Full Text] [Related]
28. [Choosing contraception for adolescents]. Wemeau-jacquemont C NPN Med; 1985 Feb; 5(84):185-9. PubMed ID: 12280585 [TBL] [Abstract][Full Text] [Related]
30. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments]. Le Coutour X NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304 [TBL] [Abstract][Full Text] [Related]
32. Managing menstrual disturbances. Barnett B Netw Res Triangle Park N C; 1995 Jun; 15(4):8. PubMed ID: 12289833 [TBL] [Abstract][Full Text] [Related]
33. [Metabolic risks of oral contraception]. Monier L Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576 [TBL] [Abstract][Full Text] [Related]
34. On 7/7/7 preferred for new patients by 47% of respondents. Contracept Technol Update; 1986 Sep; 7(9):101-4. PubMed ID: 12268337 [TBL] [Abstract][Full Text] [Related]
35. [Oral contraception: disadvantages of estrogen reduction]. Denis C Contracept Fertil Sex (Paris); 1993 Jun; 21(6):481-8. PubMed ID: 12318238 [TBL] [Abstract][Full Text] [Related]
36. Menstrual abnormalities in the adolescent abuse of the birth control pill. Spence JE Pediatr Adolesc Gynecol; 1983; 1(2):125-48. PubMed ID: 12313870 [TBL] [Abstract][Full Text] [Related]
37. Headaches: OCs are "guilty by association". Contracept Technol Update; 1993 Jul; 14(7):109-12. PubMed ID: 12286998 [TBL] [Abstract][Full Text] [Related]
38. Instructions for combined pill users. Reese M; Hatcher RA Contracept Technol Update; 1985 Jan; 6(1):19-20. PubMed ID: 12279914 [TBL] [Abstract][Full Text] [Related]
39. [Cutaneous effects in hormonal contraception]. Thomas P; Dalle E; Revillon B; Delecour M; Devarenne-nicolle MF; Pagniez I NPN Med; 1985 Jan; 5(81):19-24. PubMed ID: 12281276 [TBL] [Abstract][Full Text] [Related]
40. Potential risks, benefits of progestins in birth control pills outlined. Contracept Technol Update; 1984 Jun; 5(6):71. PubMed ID: 12313083 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]